Zantac / Ranitidine (NDMA Cancer) Lawsuit in Massachusetts

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

Massachusetts has a 3-year statute of limitations for personal injury claims (Mass. Gen. Laws c. 260, § 2A) with the discovery rule applicable. Massachusetts courts apply the Daubert standard for expert testimony (Commonwealth v. Lanigan). The 3-year SOL is more favorable than 2-year states, giving Massachusetts Zantac claimants more time for diagnoses from 2021 onward. Massachusetts' sophisticated legal community and major pharmaceutical industry presence make it a capable Zantac litigation venue.

3 years from date of cancer diagnosis discovery (Daubert standard; 3-year SOL favorable)

Massachusetts Data

Exposure in Massachusetts

Source: U.S. Census Bureau 2024

Source: Massachusetts Cancer Registry 2024

Source: Mass. Gen. Laws c. 260, § 2A

Medical Resources

Clinics & Specialists in Massachusetts

Dana-Farber Cancer Institute

Mass General Cancer Center

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview